 
		
	                PDB-code
	                
	                        
	                
	        
		Search results (134 entries covering 100 PDB structures)
 
				| # | Kinase | Family | Group | PDB | Chain | (Alternate) Model | Orthosteric ligand | Organism | Details | File | 
|---|---|---|---|---|---|---|---|---|---|---|
|  | PIK3CA (p110a) | PIK | Atypical | 8twy | A | n-[4-[5-(1,2,4-oxadiazol-3-yl)thiophen-2-yl]pyridin-2-yl]cyclopropanecarboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8exo | A | B | 1-{(4s,11am)-2-[(4r)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-prolinamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8exl | A | A | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8exo | A | A | 1-{(4s,11am)-2-[(4r)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-prolinamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8exv | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8gud | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 6gvh | A | A | 5-(6-azanyl-4-chloranyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8sbc | A | A | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1h-imidazo[4,5-b]pyridine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7pg6 | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7tz7 | A | A | (4s,5r)-3-[2'-amino-2-(morpholin-4-yl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-1,3-oxazolidin-2-one | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7myn | A | B | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8v8i | A | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8v8v | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8v8u | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8v8j | A | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7tz7 | A | B | (4s,5r)-3-[2'-amino-2-(morpholin-4-yl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-1,3-oxazolidin-2-one | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5uk8 | A | B | (r)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1h-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 4ovu | A | B | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 6pys | A | B | (3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 4ovv | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7mlk | A | B | 4-[6-(3,4,5-trimethoxyanilino)pyrazin-2-yl]benzamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 4ovu | A | A | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5sxb | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5swo | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5sxc | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8tgd | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8ils | A | B | n-[(2r)-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8tu6 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8ilv | A | n-[(2r)-1-(ethylamino)-1-oxidanylidene-3-[3-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8w9b | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8w9a | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5fi4 | A | B | ~{n}-[6-[5-azanyl-6-[(2~{s})-1,1,1-tris(fluoranyl)propan-2-yl]oxy-pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]ethanamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8ow2 | A | A | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8tsb | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8tsc | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8ts7 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8ts9 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8tsa | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7myo | B | A | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5fi4 | A | A | ~{n}-[6-[5-azanyl-6-[(2~{s})-1,1,1-tris(fluoranyl)propan-2-yl]oxy-pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]ethanamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 6oac | A | 4-(difluoromethyl)-5-{4-[(3s)-3-methylmorpholin-4-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}pyridin-2-amine | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4tuu | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5ul1 | A | B | 3-amino-6-(4-{[(2s)-1-(dimethylamino)propan-2-yl]sulfonyl}phenyl)-n-phenylpyrazine-2-carboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 4l1b | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7k6n | A | B | tert-butyl (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 6gvf | A | B | 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 6gvf | A | A | 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7myn | A | A | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5swg | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5swr | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7k71 | A | 2-(morpholin-4-yl)[4,5'-bipyrimidin]-2'-amine | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5sx9 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 6gvi | A | B | 3-(2-azanyl-1,3-benzoxazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-d]pyrimidine-4,6-diamine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7r9v | A | n-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-1-(prop-2-enoyl)piperidine-4-carboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4waf | A | B | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5ubr | A | 1-[4-(3-{4-amino-5-[1-(oxan-4-yl)-1h-pyrazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)piperazin-1-yl]ethan-1-one | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4jps | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7k6n | A | A | tert-butyl (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5sw8 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5dxh | D | methyl {2-[4-(2-chlorophenyl)-4h-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepin-8-yl}carbamate | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5sx8 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5swp | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5sxd | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5dxh | A | methyl {2-[4-(2-chlorophenyl)-4h-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepin-8-yl}carbamate | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4zop | A | B | (2s,3r)-n~1~-(8-tert-butyl-4,5-dihydro[1,3]thiazolo[4,5-h]quinazolin-2-yl)-3-methylpyrrolidine-1,2-dicarboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7myo | B | B | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 4ykn | A | A | 3-(6-methoxypyridin-3-yl)-5-[({4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}amino)methyl]benzoic acid | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 6nct | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5sxf | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 6gvh | A | B | 5-(6-azanyl-4-chloranyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5swt | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4zop | A | A | (2s,3r)-n~1~-(8-tert-butyl-4,5-dihydro[1,3]thiazolo[4,5-h]quinazolin-2-yl)-3-methylpyrrolidine-1,2-dicarboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5xgi | A | 3-azanyl-5-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8tdu | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8ts8 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7jiu | A | B | (3s)-3-benzyl-5-[9-ethyl-8-(2-methylpyrimidin-5-yl)-9h-purin-6-yl]-3-methyl-1,3-dihydro-2h-indol-2-one | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5sxe | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5xgh | A | 3-[(4-fluorophenyl)methylamino]-5-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4waf | A | A | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5sxk | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7k6m | A | B | 2,2-difluoroethyl (3s)-3-{[2'-amino-5-fluoro-2-(morpholin-4-yl)[4,5'-bipyrimidin]-6-yl]amino}-3-(hydroxymethyl)pyrrolidine-1-carboxylate | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5sxi | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7r9y | A | n-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-n-methyl-1-(prop-2-enoyl)piperidine-4-carboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 3hhm | A | (1s,6br,9as,11r,11br)-9a,11b-dimethyl-1-[(methyloxy)methyl]-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3h-furo[4,3,2-de]indeno[4,5-h][2]benzopyran-11-yl acetate | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8am0 | A | (2r)-2-[[2-[(4s)-4-[bis(fluoranyl)methyl]-2-oxidanylidene-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8tdu | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 6gvi | A | A | 3-(2-azanyl-1,3-benzoxazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-d]pyrimidine-4,6-diamine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5itd | A | 5-{4-[3-(4-acetylpiperazine-1-carbonyl)phenyl]quinazolin-6-yl}-2-methoxypyridine-3-carbonitrile | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8bfu | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8sbj | A | B | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(1h-pyrazol-3-yl)-3h-imidazo[4,5-b]pyridine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8dd8 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8sbj | A | A | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(1h-pyrazol-3-yl)-3h-imidazo[4,5-b]pyridine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7pg5 | A | A | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8dcp | A | B | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5ul1 | A | A | 3-amino-6-(4-{[(2s)-1-(dimethylamino)propan-2-yl]sulfonyl}phenyl)-n-phenylpyrazine-2-carboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7k6o | A | B | (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-n-methylpyrrolidine-1-sulfonamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5sxj | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5dxt | A | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7pg5 | A | B | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5sxa | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7jiu | A | A | (3s)-3-benzyl-5-[9-ethyl-8-(2-methylpyrimidin-5-yl)-9h-purin-6-yl]-3-methyl-1,3-dihydro-2h-indol-2-one | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7mlk | A | A | 4-[6-(3,4,5-trimethoxyanilino)pyrazin-2-yl]benzamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8v8h | A | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8exl | A | B | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 7k6m | A | A | 2,2-difluoroethyl (3s)-3-{[2'-amino-5-fluoro-2-(morpholin-4-yl)[4,5'-bipyrimidin]-6-yl]amino}-3-(hydroxymethyl)pyrrolidine-1-carboxylate | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8dcx | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8ilr | A | B | n-[(2s)-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 3zim | A | 1-[4-[[2-(1h-indazol-4-yl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-6-methyl-hept-5-ene-1,4-dione | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4tv3 | A | 2-amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8h)-one | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 5uk8 | A | A | (r)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1h-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5ukj | A | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7k6o | A | A | (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-n-methylpyrrolidine-1-sulfonamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 2rd0 | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4l23 | A | 3-(4-morpholin-4-ylpyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 6pys | A | A | (3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 4l2y | A | 3-amino-5-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 6gvg | A | 5-(6-azanyl-4-methyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 3hiz | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4jps | A | B | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8exv | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 5xgj | A | 3-(4-morpholin-4-ylfuro[3,2-d]pyrimidin-2-yl)-5-[(phenylmethyl)amino]phenol | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 4ykn | A | B | 3-(6-methoxypyridin-3-yl)-5-[({4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}amino)methyl]benzoic acid | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8exu | A | A | (2s)-2-cyclopropyl-2-({(4s,11am)-2-[(4s)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)acetamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8gua | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8ow2 | A | B | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8dd4 | A | A | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8dd4 | A | B | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8sbc | A | B | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1h-imidazo[4,5-b]pyridine | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8dcp | A | A | - | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8tsd | A | - | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 7pg6 | A | B | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8tgd | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | Show |  | 
|  | PIK3CA (p110a) | PIK | Atypical | 8gub | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | Show |  | |
|  | PIK3CA (p110a) | PIK | Atypical | 8exu | A | B | (2s)-2-cyclopropyl-2-({(4s,11am)-2-[(4s)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)acetamide | Human | Show |  | 
